terized enzymes are involved in NAD + , cADPR, and
). This would suggest that both cADPR and H 2 O 2 might activate In addition, maximal currents induced by these stimuli usually remained below 5% of those typically achieved TRPM2 through a common 8-Br-cADPR-sensitive mechanism, whereas ADPR and NAD + activate TRPM2 indeby ADPR. This would suggest that cADPR and H 2 O 2 may gate TRPM2 directly, but their efficacy appears too pendently through an AMP-sensitive, but 8-Br-cADPRindependent, mechanism. low to bear physiological significance.
To assess whether the effects of cADPR were secAs evident from Figures 4C and 4D , 8-Br-cADPR actually accelerated the kinetics of ADPR-and NAD + -ondary to intracellular metabolism, we performed single-channel recordings in excised membrane patches mediated activation of TRPM2, and we considered the possibility that the gating mechanisms of ADPR/NAD + where such conversion would likely be absent. Consistent with the small cADPR-mediated, whole-cell curand cADPR/H 2 O 2 might involve some form of cooperativity or synergy. To test this, we stimulated cells with rents, it proved difficult to obtain cADPR-induced, single-channel activity in excised membrane patches.
combinations of various agonists at concentrations that were below the threshold for activating TRPM2 Only one out of eight membrane patches exposed to 1 mM cADPR induced multichannel openings with the when used individually. As illustrated in Figure 5A , the combination of 10 M cADPR and various subthreshold typical long open times of TRPM2 ( Figure 2H ). All other patches were either silent or showed only rare channel concentrations of ADPR caused a strong activation of TRPM2 with an IC 50 of 90 nM. Thus, the presence of activity with brief openings. In contrast, 100 M ADPR reliably (eight out of 12 patches) caused multichannel cADPR caused a 100-fold shift in TRPM2's sensitivity to ADPR ( Figure 5B ), demonstrating that TRPM2 activity is activity of up to 16 channels per patch ( Figure 2G ). Because HPLC analysis of our cADPR lot did not reveal synergistically enhanced when the channel binds two agonists. This synergy occurred over a narrow sub-ADPR as an appreciable contaminant, these data would suggest that cADPR has some limited capability threshold concentration range of cADPR and ADPR, because lowering the concentration of either cADPR to to gate TRPM2 channels directly.
Because ADPR is subject to metabolic breakdown 3 M while maintaining ADPR at 300 nM (data not shown) or reducing ADPR to 10 nM while keeping into ribose 5-phosphate and AMP, we tested for possible effects of these two metabolites on ADPR-medicADPR at 10 M was largely ineffective in triggering TRPM2 activity ( Figure 5A ). Disruption of this synergy ated activation of TRPM2. Consistent with our previous findings (Perraud et al., 2001) , neither of the two metabby adding 500 M AMP caused complete suppression of TRPM2 currents. olites activated TRPM2 at concentrations up to 1 mM (data not shown). We also found no obvious inhibitory Because our previous experiments suggested that H 2 O 2 behaves similarly to cADPR, we tested whether effect of ribose 5-phosphate (100 M) on TRPM2 currents induced by 30 M ADPR ( Figure 3A) . In contrast, subthreshold concentrations of 10-30 M H 2 O 2 could synergize with 300 nM ADPR in a similar fashion as AMP exhibited a potent dose-dependent inhibition of ADPR-induced currents (Figure 3B ), where 100 M subtreshold levels of cADPR. At these subthreshold H 2 O 2 concentrations, we did not observe significant AMP caused w70% inhibition, and 300 M AMP essentially abolished any current response to 100 M ADPR. potentiation (data not shown). However, increasing the H 2 O 2 concentration to 100 M, which by itself typically The dose-response relationship of this inhibitory effect is illustrated in Figure 3C , and the fit to these data causes less than 5% of the maximal achievable TRPM2 current, induced large currents in excess of 15 nA at yielded an IC 50 of w70 M. The antagonistic action of AMP allowed us to test whether it affected any of the −80 mV even when the ADPR concentration was as low as 300 nM ( Figure 5C ). As in the case of combining other agonists. Figure 3D illustrates that 500 M AMP also completely suppressed TRPM2 activation by 1 mM cADPR and ADPR, addition of 500 M AMP to the synergistic combination of H 2 O 2 and ADPR completely NAD + (or its ADPR contaminant). However, the same concentration of AMP was ineffective at antagonizing suppressed activation of TRPM2. We also assessed the possible synergy of 10 M cADPR and 300 M NAD + , the small currents evoked by either 1 mM cADPR (Figure 3E) or 100 M H 2 O 2 ( Figure 3F) , which implies that which both represent ineffective concentrations when applied individually. As with ADPR, we observed a the inhibition is specific for the agonist and not due to a simple block of the channel. These results therefore strong facilitation of TRPM2 activation ( Figure 5D ), yielding large currents that were almost identical to indicate that the ADPR-mediated TRPM2 activation mechanism is susceptible to AMP inhibition and disthose observed with 1 mM NAD + alone. AMP proved effective in suppressing this effect. However, because tinct from the AMP-insensitive channel activity induced by cADPR or H 2 O 2 .
we know that NAD + is contaminated with ADPR, these effects are likely attributable to the synergy of cADPR Previous work has established 8-Br-cADPR as a selective and potent antagonist of cADPR-mediated Ca 2+ with ADPR rather than NAD + . A somewhat surprising aspect of the synergy besignaling (Walseth and Lee, 1993), prompting us to test Figure 5G) . However, the large InsP 3 -mediated Ca 2+ release transients did not cause TRPM2 shown). Thus, 8-Br-cADPR has a dual effect in that it inhibits cADPR-and H 2 O 2 -mediated gating of TRPM2 activation and therefore failed to synergize with 300 nM ADPR, a concentration at which cADPR fully potentibut at the same time can mimic their effects in synergizing with ADPR. This behavior is typical of a partial ates TRPM2 activation. Thus, we conclude that the cADPR-mediated potentiation effect is not rooted in a agonist.
Because one of the established mechanisms of possible Ca 2+ release mechanism. cADPR, at least in some cell types, encompasses Ca Considering that 30 nM ADPR in combination with 10 M cADPR already yielded several nanoamperes of the present study, we used a more physiological K-glutamate-based intracellular solution in which Ca 2+ was TRPM2 current (see Figure 5A ) and that even 1 mM cADPR produced only about 0.5 nA of current (see Fignot The cADPR-mediated activation of TRPM2 appears tor to release internal calcium stores. There is, however, some indication that cADPR may also play a role in to result from a direct gating mechanism, because TRPM2 activation by cADPR was relatively rapid in calcium entry in some cell types. Thus, cADPR was found to induce Ca 2+ influx in T cells by producing whole-cell recordings (see Figure 2D) levels, it could well synergize with nanomolar concentrations of ADPR to activate TRPM2. This provides a
